Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.

Also called NCT07301372

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 132 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT07301372
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07301372. Randomized; single masking; primary purpose treatment. Start 2025-10-30 (actual); primary completion 2026-03-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke
Acronym
EPOCH-LYSIS
Condition
Acute Stroke
Intervention (Drug)
Ivolumab 420mg (three vials)
Lead sponsor
The Affiliated Hospital of Xuzhou Medical University (class: other)

Record details

Record id
cardio:ct-nct07301372
Content hash
694dedf9020e43afba58f2ef7c4fc01af5b5c75e01acfd3d0d4fc24e0bccf6fe